Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-01-27
2010-12-07
Kolker, Daniel E (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007800, C800S003000
Reexamination Certificate
active
07846671
ABSTRACT:
The present invention provides methods that are useful for the treatment or prevention of smooth muscle disorders such as urinary incontinence and compounds that are useful in such methods.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 5846780 (1998-12-01), Levinson et al.
patent: 5869509 (1999-02-01), Romine et al.
patent: 6069296 (2000-05-01), Horvitz et al.
patent: 6077861 (2000-06-01), Romine et al.
patent: 6410240 (2002-06-01), Hodge et al.
patent: 6551786 (2003-04-01), Manfredi
patent: 6613786 (2003-09-01), Hewawasam et al.
patent: 2003/0144333 (2003-07-01), Hewawasam et al.
patent: 2007/0065883 (2007-03-01), Cockett et al.
patent: 1276371 (2001-11-01), None
patent: WO 98/06737 (1998-02-01), None
patent: WO 99/66324 (1999-12-01), None
patent: WO 01/19984 (2001-03-01), None
patent: WO 01/44197 (2001-06-01), None
patent: WO 01/83514 (2001-11-01), None
patent: WO 01/84921 (2001-11-01), None
patent: WO 01/85769 (2001-11-01), None
patent: WO 02/50104 (2002-06-01), None
Cunningham et al. Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling. J Biol Chem. Feb. 23, 2001;276(8):5438-44. Epub Nov. 3, 2000.
Dowal et al. Determination of the contact energies between a regulator of G protein signaling and G protein subunits and phospholipase C beta 1. Biochemistry. Jan. 16, 2001; 40(2): 414-21.
Ogura et al. Block and modified gating of cardiac calcium channel currents by terodiline. Br J Pharmacol. Aug. 1999; 127(8): 1837-45).
Mickle et al. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am. May 2000;84(3):597-607.
Voet et al. Biochemistry. 1990. John Wiley & Sons, Inc. 126-129 and 228-234.
Yan et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290: 523-527, 2000.
De Vries et al. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol. 2000;40:235-71.
Heximer et al. RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci U S A. Dec. 23, 1997;94(26):14389-93.
Hegde et al. Peripheral 5-HT4 receptors. FASEB J. Oct. 1996;10(12):1398-407.
Berridge, et al., “The Versatility and Universatility of Calcium Signalling”,Nature, (2000), 1, pp. 11-21.
Brenner, “The Genetics ofCaenorhabditis elegans”, Genetics, (1974), 77, pp. 71-94.
Janetopoulous, et al., “Receptor-Mediated Activation of Heterotrimeric G-Proteins in Living Cells”Science, (2001), 291, pp. 2408-2410.
Malkowicz, et al., “Acute Biochemical and Functional Alterations in the Partially Obstructed Rabbit Urinary Bladder”,J. Urol., (1986), 136, pp. 1324-1329.
Meng, et al., “Automated Docking With Grid-Based Energy Evaluiation”,J. Comp. Chem., (1992), 13, pp. 505-524.
Moy, et al., “NMR Structure of Free RGS4 Reveals an Induced Conformational Change Upon Binding Gα,”Biochem., (2000), 39(24), pp. 7063-7073.
Razvi, E.S., “Industry Trends in High-Throughput Screening,”Drug&Market Development Publications, (2000).
Razvi, E.S., “High-Throughput Screening—Where Are We Today?”Drug&Market Development Publications, (1999).
Slep, et al., “Structural Determinants for Regulation of Phospodiesterase by a G-Protein at 2.0 .,”Nature, (2001), 409, 1071.
Tesmer, et al., “Structure of RGS4 Bound to ALF4(-)-Activated G(I Alpha1): Stabilization of The transition State for GTP Hydrolysis,”Cell, (1997), pp. 251-261.
Tesmer, et al., “Molecular Basis for P-Site Inhibition of Adenlyl Cyclase,”Biochem., (2000), 39, 14464.
Weber, “Ion Currents ofXenopus laevisOocytes: State of Art”,Biochim. Biophys. Acta, (1999), 1421, pp. 213-233.
Zhong, et al., “Regulator of G Protein Signalling Proteins: Novel Multifunctional Drug Targets”,Perspectives in Pharmacology, (2001), 297, pp. 837-845.
Zhu, et al., “Receptor-Activated Ca2+Infux Via Human Trp3 Stably Expressed in Human Embryonic Kidney (HEK) 293 Cells”J Biol. Chem., 273, pp. 133-142.
NCBI Entrez Accession No. gi|AAB04059, Brudage, L. et al., Jul. 18, 1996.
NCBI Entrez Accession No. gi|XM—001330, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|XM—002185, NCBI Annotation Project, May 8, 2002.
NCBI Entrez Accession No. gi|XM—005324, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|XM—010645, NCBI Annotation Project, May 13, 2002.
NCBI Entrez Accession No. gi|XM—027292, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|XM—027524, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|XM—027525, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|XM—029884, NCBI Annotation Project, May 8, 2002.
NCBI Entrez Accession No. gi|XM—032141, NCBI Annotation Project, May 13, 2002.
NCBI Entrez Accession No. gi|XM—034023, NCBI Annotation Project, May 8, 2002.
NCBI Entrez Accession No. gi|XM—046463, NCBI Annotation Project, Dec. 11, 2001.
NCBI Entrez Accession No. gi|1181671, Dong, Q. et al., Feb. 7, 1996.
NCBI Entrez Accession No. gi|1354761, Brundage, L. et al., Jul. 19, 1996.
NCBI Entrez Accession No. gi|2398571, Barlow, K., Dec. 3, 2003.
NCBI Entrez Accession No. gi|8394182, Garnier, M. et al., Oct. 5, 2003.
NCBI Entrez Accession No. gi|12620875, Gabbeta, J. et al., Jan. 31, 2001.
Abagyan, R. et al., “Biased Probability Monte Carlo Conformational Searches and Electrostatic Calculations for Peptides and Proteins,” J. Mol. Biol., vol. 235, pp. 983-1002 (1994).
Abagyan, R. et al., “ICM—A New Method for Protein Modeling and Design: Applications to Docking and Structure Prediction from the Distorted Native Conformation,” Journal of Computational Chemistry, vol. 15, No. 5, pp. 488-506 (1994).
Ausubel, F.M. et al., eds., Current Protocols in Molecular Biology, vols. 1-4, John Wiley & Sons, Inc., publ., pp. 1-11 (table of contents) (1994).
Bartlett, P.A. et al., “CAVEAT: A Program to Facilitate the Structure-derived Design of Biologically Active Molecules,” Molecular Recognition: Chemical and Biochemical Problems, The Proceedings of an International Symposium, University of Exeter, Special Publ. No. 78, pp. 182-196 (Apr. 1989).
Böhm, H.-J., “The computer program LUDI: A new method for the de novo design of enzyme inhibitors,” Journal of Computer-Aided Molecular Design, vol. 6, pp. 61-78 (1992).
Bowen, J.P. et al., Chapter 3: “Molecular Mechanics: The Art and Science of Parameterization,” Reviews in Computational Chemistry II, VCH Publishers, Inc., publ., Lipkowitz, K.B. et al., eds., pp. 81-97 (1991).
Brooks, B.R. et al., “CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations,” Journal of Computational Chemistry, vol. 4, No. 2, pp. 187-217 (1983).
Brundage, L. et al., “Mutations in aC. elegansGqα Gene Disrupt Movement, Egg Laying, and Viability,” Neuron, vol. 16, pp. 999-1009 (1996).
Cohen, N.C. et al., “Molecular Modeling Software and Methods for Medicinal Chemistry,” Journal of Medicinal Chemistry, vol. 33, No. 3, pp. 883-894 (1990).
Creighton, T.E., Proteins: Structures and Molecular Principles, W.H. Freeman and Company, publ., pp. v-viii (table of contents) (1984).
Dalby, A. et al., “Description of Several Chemical Structure File Formats Used by Computer Programs Developed at Molecular Design Limited,” J. Chem. Inf. Comput. Sci., vol. 32, pp. 244-255 (1992).
Fingl, E. et al., Chapter 1: “General Principles,” The Pharmacological Basis of Therapeutics, 5thEd., Macmillan Publishing Co., Inc., publ., Goodman, L.S. et al., eds., pp. 1-46 (1975).
Goodford, P.J., “A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules,” J. Med. Chem., vol. 28, pp. 849-857 (1985).
Goodsell, D.S. et al.,
Cockett Mark
Doberstein Stephen Kohl
Fitzgerald Kevin
Kindt Rachel M.
Kopczynski Jenny
Bristol--Myers Squibb Company
D'Amico Stephen C.
Emch Gregory S
Kolker Daniel E
LandOfFree
Methods of screening for agents that modulate the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for agents that modulate the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for agents that modulate the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194055